40 Hz Gamma Stimulation and Alzheimer's Disease

40Hz

Gamma frequency of stimulation — the precise resonance that entrains healthy brain oscillations

200%+

Increase in CSF amyloid-β after 7 days of stimulation in aged rhesus monkeys (Wang et al., 2026)

5+wk

Duration of elevated CSF Aβ clearance in primates — far longer than in any rodent study to date

670

Patients enrolled in Cognito's HOPE Phase 3 trial — the largest Alzheimer's device trial in history

01 · Background

Why Gamma Oscillations Matter in Alzheimer's

The Gamma Deficit

🧠

Healthy Brain

Strong, synchronised γ waves

→

🧠

Alzheimer's Brain

Disrupted, weakened γ activity

Current Treatment Limitations

FDA-approved antibody drugs (lecanemab, donanemab) slow decline by only ~30% vs. placebo after 18 months
Cerebral haemorrhage rates of 6.8–22.1% and cerebral oedema in 9.9–36% of treated patients
High cost, IV administration, regular hospital visits required
Effective only in early-stage patients; no reversal of disease progression
Drug failures in >95% of AD clinical trials from rodent models

02 · Mechanism of Action

How 40 Hz Stimulation Clears Amyloid

👁️🎵

Sensory Entrainment

When you listen to Gamma40 audio, the 40 pulses per second act like a metronome for your brain. Neurons gradually synchronise their firing to match that rhythm, just like a crowd clapping in time with music. This is called entrainment, and it is where everything begins.

🔌

VIP Interneuron Activation

Once neurons fire in gamma rhythm, they signal VIP interneurons, specialised nerve cells that act as traffic controllers for the brain's blood vessels. These cells tell nearby vessels to relax and widen slightly, increasing blood flow. Think of it as the brain unlocking its own plumbing system.

💧

AQP4 Polarisation

Each brain cell is wrapped by support cells called astrocytes. They contain tiny water gates (AQP4 channels) that normally sit in a disorganised state. The gamma rhythm causes these gates to line up and open together, allowing cerebrospinal fluid (the brain's natural rinsing liquid) to flow in much more freely.

🫀

Arterial Pulsatility + Lymphatic Dilation

With the water gates open and blood flow increased, the natural pulse of the arteries acts like a pump, pushing fresh rinsing fluid deeper into brain tissue. At the same time, the lymphatic vessels along the brain's surface widen to create a larger drain. Together they drive waste-laden fluid outward.

🧹

Glymphatic Aβ Clearance

The rinsing fluid sweeps through the brain like a wash cycle, picking up amyloid-β, the sticky protein that accumulates into Alzheimer's plaques. This waste-laden fluid drains into the lymphatic system and out of the brain entirely. In the 2026 primate study, this was so effective that amyloid levels in the fluid more than doubled after just 7 days (Higher CSF amyloid = more cleared from brain tissue — not more accumulation.)

Source: Murdock et al. (2024) Nature — nature.com/articles/s41586-024-07132-6

03 · Delivery Modalities

How the Stimulation is Applied

💡

Visual / Photic

LED Flicker

An LED panel or screen flickers at exactly 40 times per second. The retina transmits the signal to the occipital and temporal cortex. Precise timing is critical — random 40Hz ambient light has no effect.

Targets: Visual cortex → broad cortical spread

🔊

Auditory

Pulsed Sound

1 kHz pure tones pulsed at 40Hz (1ms on / 24ms off) at ~60 dB. Used in the Wang et al. monkey study. Directly targets temporal lobe — the brain region most affected by AD pathology.

1kHz · 1ms pulses · 40Hz · 60dB SPL

✨

Combined Multisensory

Audio + Visual

Synchronised light and sound produces the strongest entrainment — spreading to prefrontal cortex, hippocampus, and subcortical structures. The combination activates an additional brain region beyond the sum of each modality alone.

Best clinical outcomes · Used in GENUS, Spectris AD

04 · Key Evidence

Major Studies & Findings

Mouse 2016

Gamma Entrainment Reduces Amyloid in Visual Cortex

40Hz light stimulation induced gamma oscillations reducing amyloid levels and plaque loads in the primary visual cortex of transgenic AD mice — the founding study of this field.

Iaccarino et al. Nature 540, 230–235

doi.org/10.1038/nature20587 ↗

Mouse 2019

Combined Audio-Visual GENUS Improves Cognition

Multi-sensory 40Hz stimulation reduced plaque loads in hippocampus and temporal cortex, and significantly improved performance in spatial memory and object recognition tasks.

Martorell et al. Cell 177, 256–271

doi.org/10.1016/j.cell.2019.02.014 ↗

Mouse 2024

Glymphatic Mechanism Confirmed in Nature

Multisensory gamma stimulation promotes CSF influx and interstitial fluid efflux via AQP4 polarisation, arterial pulsatility and VIP interneurons. Blocking glymphatic clearance abolished amyloid removal.

Murdock et al. Nature 627, 149–156

doi.org/10.1038/s41586-024-07132-6 ↗

Primate 2026

First Primate Study: 200%+ CSF Aβ Rise, 5-Week Duration

7 days of 40Hz auditory stimulation in 9 aged rhesus monkeys raised CSF Aβ by >200%. Remarkably, the effect persisted for 5+ weeks post-cessation — never seen in rodents. Postmortem confirmed widespread Aβ plaques cleared.

Wang, Huang, Lv et al. PNAS 123(2) e2529565123

doi.org/10.1073/pnas.2529565123 ↗

Human 2022

Phase 1/2A: Safe, Entrains Hippocampus and Amygdala

3 months of daily GENUS light+sound in 15 mild AD patients: reduced ventricular dilation, reduced hippocampal atrophy, improved default mode connectivity, better delayed recall. First human entrainment confirmed in subcortical structures.

Chan et al. PLOS One 17, e0278412

doi.org/10.1371/journal.pone.0278412 ↗

Human 2025

2-Year Extension: Cognitive Stability, Reduced pTau217

Five patients followed for ~30 months. Three late-onset AD patients maintained significantly higher cognition vs. national database comparisons. Two showed significant plasma pTau217 reduction — direct biomarker evidence of disease modification.

Chan, Tsai et al. Alzheimer's & Dementia

doi.org/10.1002/alz.70792 ↗

05 · Clinical Outcomes

Results from the OVERTURE Trial (Cognito, n=76, 6 months)

Reduction in cognitive decline (vs sham) 76%

Reduction in functional decline (vs sham) 77%

Reduction in whole-brain atrophy (MRI) 69%

Source: Cognito Therapeutics OVERTURE study (NCT03556280). Note: these are feasibility study estimates pending Phase 3 confirmation.

CSF Aβ increase in primates after 7 days >200%

Duration of Aβ elevation after cessation 35+ days

Tau effect (CSF) — not significant ~0%

Tau null result explained by absent tau pathology in aged monkey brains at time of study (Wang et al. 2026).

06 · Clinical Devices

Devices Used in Research & Trials

Device	Developer	Modality	Status	Trial / Reference
Spectris AD™	Cognito Therapeutics	Wearable goggles + audio headset	Phase 3 HOPE	NCT05637801 ↗
GENUS Device	MIT Picower Institute	LED panel + speaker, home-based	Phase 2 trials	NCT04042922 ↗
Custom Speakers	Wang et al. (KIZ/CAS)	Loudspeakers, 1kHz pulsed at 40Hz	Animal research	PNAS 2026 ↗
NextWave Chair	NextWave Neuro	Tactile vibration at 40Hz (whole body)	Early research	Preclinical
tACS (40Hz)	Various academic groups	Transcranial alternating current stimulation	Phase 2	Harvard, 2022 — reduced tau in 3/4 volunteers

07 · Limitations & Open Questions

What We Still Don't Know

🔬

Small Sample Sizes

Most human trials have <20 participants. The primate study used only n=3 per group. Phase 3 HOPE trial (n=670) is essential for definitive conclusions.

❓

Mechanism Partially Inferred

The glymphatic mechanism is well-supported in mice but has not been directly measured in primates or humans. AQP4, arterial pulsatility, and VIP effects remain to be confirmed in vivo in primates.

📈

CSF Aβ Rise ≠ Proof of Clearance

Elevated CSF Aβ is interpreted as plaques being dissolved and cleared, but the study did not directly measure reduced plaque burden (e.g., via serial PET imaging) in the same animals.

⚡

Conflicting Rodent Data

Soula et al. (Nat. Neurosci. 2023) found that 40Hz visual stimulation failed to introduce gamma oscillations or reduce Aβ in their AD mouse model — challenging the rodent evidence base.

👥

Patient Subgroup Variability

The 2-year MIT study found benefits only in late-onset (not early-onset) AD patients, and only in female participants. Disease stage and genetics likely matter significantly.

🏠

Precision Delivery Required

Consumer-grade "40Hz" audio/video (e.g., YouTube flicker videos) lacks the precise temporal calibration and entrainment verification of clinical devices. DIY approaches should not be assumed equivalent.

References

Full Citation List

[1] Wang et al. (2026) — Long-term effects of forty-hertz auditory stimulation as a treatment of Alzheimer's disease: Insights from an aged monkey model study. PNAS 123(2). https://doi.org/10.1073/pnas.2529565123

[2] Iaccarino et al. (2016) — Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature 540, 230–235. https://doi.org/10.1038/nature20587

[3] Martorell et al. (2019) — Multi-sensory gamma stimulation ameliorates Alzheimer's-associated pathology and improves cognition. Cell 177, 256–271. https://doi.org/10.1016/j.cell.2019.02.014

[4] Murdock et al. (2024) — Multisensory gamma stimulation promotes glymphatic clearance of amyloid. Nature 627, 149–156. https://doi.org/10.1038/s41586-024-07132-6

[5] Chan et al. (2022) — Gamma frequency sensory stimulation in mild probable Alzheimer's dementia patients: feasibility and pilot studies. PLOS One 17, e0278412. https://doi.org/10.1371/journal.pone.0278412

[6] Chan, Tsai et al. (2025) — Gamma sensory stimulation in mild Alzheimer's dementia: An open-label extension study. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70792

[7] Hajós et al. (2024) — Safety, tolerability, and efficacy estimate of evoked gamma oscillation in mild to moderate Alzheimer's disease (OVERTURE). Front. Neurol. 15:1343588. https://doi.org/10.3389/fneur.2024.1343588

[8] Soula et al. (2023) — Forty-hertz light stimulation does not entrain native gamma oscillations in Alzheimer's disease model mice. Nat. Neurosci. 26, 570–578. [Conflicting finding] https://doi.org/10.1038/s41593-023-01270-2

[9] Cognito Therapeutics HOPE Trial — Pivotal Phase 3 study of Spectris AD in 670 patients with mild-to-moderate Alzheimer's disease. 70 US sites. 12-month treatment + 12-month OLE. https://clinicaltrials.gov/ct2/show/NCT05637801

[10] MIT News (2025) — Evidence that 40Hz gamma stimulation promotes brain health is expanding. Review of 10-year research programme. news.mit.edu/2025/…0314